11 minute read
Mar. 7, 2023
Another KRASG12C Inhibitor in Ph. III, Bayer’s Massive FXIa Ph. III Clinical Trial, and 21 Other Molecules in the News
Welcome to Phase III of Drug Hunter! Pardon our dust and please report any issues you encounter to support@drughunter.com.